Pancreatic Cancer UK, along with 22 members* of the Association of Medical Research Charities (AMRC), is working in collaboration to develop and launch AMRC Open Research, a joint publication platform.
By removing traditional barriers and delays to publication, the new platform will help charities maximise the value of donations they receive by making it possible for all results from research funded to be rapidly and openly shared.
AMRC Open Research will provide a new publication option for researchers funded by the participating charities that gives them increased control over the process. This enables them to able openly and immediately share all results from their charity funded research with the scientific community and beyond. Once published, articles will undergo invited open peer review by experts in the respective field.
By making articles available in a matter of days, rather than the typical months or years that traditional publishing can take, and by including access to the raw data, AMRC Open Research will help accelerate our understanding of conditions and diseases that affect so many lives.
All articles on AMRC Open Research will be published as open access enabling anyone to see the results of the research, including those living with or affected by the conditions being researched, the charities’ wider communities and the public. The expert peer review reports will also be posted alongside the articles, helping everyone understand the merit of the published work about health conditions and diseases.
Leanne Reynolds, Head of Research at Pancreatic Cancer UK said: “Despite pancreatic cancer being the fifth biggest cancer killer in the UK, the disease still only sees 1.9 per cent of the cancer research budget every year. This means pancreatic cancer often lags behind other cancers in terms of research breakthroughs in new treatments and methods of diagnosing the disease earlier. The more researchers that are able to openly share and build on the work of others, the faster we will see breakthroughs reaching patients.
“We’re pleased to have been involved in the launch of the new AMRC platform and hope to see more innovative and exciting research being published and freely available to everyone affected by pancreatic cancer.”
*The 23 participating charities are: Alzheimer's Research UK, Ataxia UK, Autistica, BRACE, Children’s Cancer and Leukaemia Group, Epilepsy Research UK, Macmillan Cancer Support, Meningitis Research Foundation, MQ: Transforming Mental Health, Multiple Sclerosis Society, National Eye Research Centre, National Osteoporosis Society, Pancreatic Cancer UK, Parkinson's UK, Pharmacy Research UK, Royal Hospital for Neuro-disability, Spinal Research, Stroke Association, Target Ovarian Cancer, The Brain Tumour Charity, The Cure Parkinson's Trust, The Lullaby Trust, and The Scar Free Foundation